Canada markets close in 4 hours 27 minutes

Connect Biopharma Holdings Limited (CNTB)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.6300-0.0700 (-4.12%)
As of 10:52AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 92.57M
Enterprise Value -25.62M
Trailing P/E N/A
Forward P/E 1.03
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)0.92
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA 0.19

Trading Information

Stock Price History

Beta (5Y Monthly) -0.35
52-Week Change 351.35%
S&P500 52-Week Change 324.69%
52 Week High 32.8400
52 Week Low 30.5350
50-Day Moving Average 31.6580
200-Day Moving Average 31.2485

Share Statistics

Avg Vol (3 month) 3117.58k
Avg Vol (10 day) 337.63k
Shares Outstanding 555.1M
Implied Shares Outstanding 655.1M
Float 816.05M
% Held by Insiders 141.27%
% Held by Institutions 143.81%
Shares Short (May 15, 2024) 454.14k
Short Ratio (May 15, 2024) 40.69
Short % of Float (May 15, 2024) 40.17%
Short % of Shares Outstanding (May 15, 2024) 40.10%
Shares Short (prior month Apr 15, 2024) 483.14k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-27.07%
Return on Equity (ttm)-46.03%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -64.23M
Net Income Avi to Common (ttm)-59.5M
Diluted EPS (ttm)-1.0800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)118.7M
Total Cash Per Share (mrq)2.15
Total Debt (mrq)465k
Total Debt/Equity (mrq)0.46%
Current Ratio (mrq)4.99
Book Value Per Share (mrq)1.83

Cash Flow Statement

Operating Cash Flow (ttm)-47.93M
Levered Free Cash Flow (ttm)-27.07M